In preclinical studies using gastric adenocarcinoma models, MMP9 inhibitors enhanced the cytotoxic effects of chemotherapeutic agents and suppressed distant metastasis14, supporting the rationale for combining an MMP9 inhibitor with chemotherapy. The gene discussed is MMP9; the disease is gastric adenocarcinoma.